ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children

• Status: Recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Tongji Hospital

Criteria

Inclusion Criteria:

1. Age 0-12 years old,

2. ASA I-II level;

3. Sign an informed consent form.

Exclusion Criteria:

1. Developmental delay or neurological and psychiatric disorders;

2. Severe malnutrition or severe obesity;

3. High risk of stomach fullness and reflux aspiration;

4. Allergic to benzodiazepines and opioids;

5. Those who have taken sedative, analgesic, or antidepressant drugs within 24 hours;

6. Severe sleep apnea;

7. Abnormal liver and kidney function;

8. Recently participated in other clinical studies.